Nantahala Capital Management, LLC Selecta Biosciences Inc Transaction History

Nantahala Capital Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.67 - $1.35 $22,920 - $46,182	34,209 Added 1.55%	2,234,209 $1.54 Million
Q3 2023 Nov 14, 2023	BUY	$1.02 - $1.23 $1.22 Million - $1.48 Million	1,200,000 Added 120.0%	2,200,000 $2.33 Million
Q1 2023 May 15, 2023	BUY	$1.15 - $1.89 $1.15 Million - $1.89 Million	1,000,000 New	1,000,000 $1.39 Million

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nantahala Capital Management, LLC with notifications on news.